Abstract:IntroductionWith the increasing use of health economic evaluation (HEE) in decision-making and health resource allocation and management policy design has seen an increase in HEE studies on screening programs in China l. In addition to the quantity of HEE, the quality may be of particular concern as it influences the reliability of HEE evidence adopted in policy formulation. This study sought to assess the reporting quality of HEE on screening programs over the last 20 years in China and identify potential predictors and relevant recommendations to improve the quality of study reporting.MethodsA search of HEE studies published in PubMed, Embase, CNKI and WANFANG from 2000 to 2021 was performed. Two reviewers independently extracted data and assessed the quality if reporting using the 24 item Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. The CHEERS score for each study was converted into standardized 0-1 point scale. General liner regression was used to identify predictors associated with the reporting quality.ResultsOne hundred and thirty-three studies met the inclusion criteria. The mean standardized score for the included studies was 0.56 (title), 0.64 (abstract), 0.74 (introduction), 0.58 (methods), 0.40 (results), 0.70 (discussion), and 0.54 (other section). The number and reporting quality of articles published each year showed an overall upward trend. A greater proportion of studies were published in Chinese journal (69.2%), modelling-based (54.9%), conducted by universities/research institutions (45.9%), focused on non-infectious disease (84.2%), using cost-effectiveness analysis method (50.4%), published in non-specialty journal (60.2%), and declaring the funding support (76.7%). Items related to study perspective, discount rate, measurement of effectiveness, currency and price, analytical methods, uncertainty, heterogeneity and conflicts were under-reported. Published year, journal type, first author affiliation and economic evaluation type predicted higher score in regression analyses (p<0.05).ConclusionsOverall, the quantity and quality of HEE on screening programs in China is improving, although there is a need to improve the use of on specific reporting items in the CHEERS criteria. The use of suitable evaluation guidelines will make the decision-making process more scientific.

Methodological Quality Assessment of Pharmacoeconomics Research of Infectious Diseases Published in Chinese

Quality of Pharmacoeconomic Research in China

Assessment of the quality of pharmacoeconomic evaluation literature in China

A Critical Review of Chinese Pharmacoeconomics Studies in the Last Five Years.

Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China

Systematic Review and Quality Evaluation of Pharmacoeconomic Studies on Traditional Chinese Medicines

Systems analysis and evaluation of Chinese pharmacoeconomic literatures over ifve years

System analysis and evaluation of pharmacoeconomic literatures of cancer published in China

Bibliometric Analysis of Foreign Pharmacoeconomic Literatures

PD12 Quality Assessment of Health Economic Evaluation on Screening Programs from China

[Application of health economics assessment techniques in the prevention and control of important infectious diseases: a review].

Assessment of methodology and report quality of systematic evaluation and meta-analysis of acupuncture-moxibustion in China]

Systematic Evaluation of Pharmacoeconomic Literatures on Domestic Digestive System Diseases

OP46 Assessing The Quality Of Pharmacoeconomic Evaluations About Type 2 Diabetes Mellitus Drugs In National Reimbursement Drug List

A Quality Evaluation of Nursing Intervention Studies in Mainland China: from 1979 to 2012

The Quality of Published Health Economic Evaluations on Screening Programs in China: a Systematic Review and Quantitative Appraisal

Publication and Quality of Systematic Reviews/Meta-Analyses Conducted by Hospital Pharmacists in China

PD08 A Systematic Review of Reporting Quality of Economic Evaluations in TCM in NRDL of China Based on CHEERS

Reporting quality of economic evaluations of the negotiated Traditional Chinese Medicines in national reimbursement drug list of China: A systematic review

Assessment of methodological and reporting quality of systematic reviews/meta-analysis published in Chinese Journal of Nosocomiology

Bibliometric analysis of systematic reviews/meta-analyses published by hospital pharmacists in China